Recent Quotes (30 days)

You have no recent quotes
chg | %

Medifocus Inc.  

(Public, CVE:MFS)   Watch this stock  
Find more results for MFS
+0.0050 (33.33%)
Delayed:   9:55AM EDT
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 0.02 - 0.02
52 week 0.01 - 0.08
Open 0.02
Vol / Avg. 1,000.00/38,312.00
Mkt cap 3.73M
P/E     -
Div/yield     -
EPS -0.03
Shares 184.98M
Beta 0.79
Inst. own     -
Dec 5, 2016
Q2 2017 Medifocus Inc Earnings Release (Estimated) Add to calendar
Sep 14, 2016
Q1 2017 Medifocus Inc Earnings Release

Key stats and ratios

Q2 (Jun '16) 2016
Net profit margin -50.05% -109.41%
Operating margin -14.50% -70.93%
EBITD margin - -62.99%
Return on average assets -74.36% -114.54%
Return on average equity - -
CDP Score - -


The Exchange Tower Suite 1800, 130 King Street West, PO Box 427
+1-905-3197070 (Phone)
+1-905-5176060 (Fax)

Website links


Medifocus Inc. is in the business of developing and selling medical device systems that deliver precisely focused, microwave-generated heat to diseased tissue, thereby destroying or shrinking it. The Company owns over three technology platforms. The Endo-thermotherapy Platform is a catheter-based focused heat technology platform that utilizes natural body openings to deliver microwave thermotherapy to the diseased sites. The Prolieve Thermodilatation System for the treatment of Benign Prostatic Hyperplasia was developed based on the Endo-thermotherapy Platform. The Adaptive Phased Array (APA) Microwave Focusing Platform directs precisely focused microwave energy at tumor center to induce shrinkage or eradication of tumors without undue harm to surrounding tissue. The Heat-Activated and Tumor-Targeted Immunotherapy and Gene Therapy Technology is used for the development of heat-activated and tumor-targeted immunotherapy and gene therapy for the treatment of cancers and other diseases.

Officers and directors

Grant B. Walsh Chairman of the Board
Age: 63
William W. Jow M.D. Chief Executive Officer, Director
Mirsad Jakubovic Chief Financial Officer
John Mon Chief Operating Officer
Raymond Tong Director
Shuen Chuen Chan Independent Director
Age: 65
Augustine Pok Yu Chow Ph.D. Independent Director
Tak Cheung Yam Independent Director
Age: 52